Nate joined Lumanity in 2022 following the acquisition of Endpoint Outcomes, where he continues to lead projects that involve the development and validation of health outcomes measures, including patient-reported and observer-reported questionnaires, and clinician-completed screening forms. Nate has experience in multiple aspects of the development process of health outcomes measures, including interviewing patients and caregivers; qualitative data analysis; preparation of project reports and manuscripts; quantitative data collection and management; and drafting regulatory dossiers in support of labeling claims.
Nate also has experience conducting Delphi panels, which have led to establishing expert consensus in new treatment paradigms and aiding in the development of clinician-reported and patient-reported measures. Nate has experience in numerous therapeutic areas including dermatology, gastrointestinal disorders, gynecology, neurology, ophthalmology, pain, pediatric congenital diseases, oncology and urology.
Nate previously worked at Adelphi (Mapi) Values, conducting qualitative research to support the development and evaluation of clinical outcomes assessments. He received his MPH from Tufts University and BS in Human Biology from Michigan State University.